ABSTRACT
Objectives Integrating electronic health records (EHR) data from several clinical sites offers great opportunities to improve estimation with a more general population compared to analyses based on a single clinical site. However, sharing patient-level data across sites is practically challenging due to concerns about maintaining patient privacy. The objective of this study is to develop a novel distributed algorithm to integrate heterogeneous EHR data from multiple clinical sites without sharing patient-level data.
Materials and Methods The proposed distributed algorithm for binary regression can effectively account for between-site heterogeneity and is communication-efficient. Our method is built on a pairwise likelihood function in the extended Mantel-Haenszel regression, which is known to be statistically highly efficient. We construct a surrogate pairwise likelihood function through approximating the target pairwise likelihood by its surrogate. We show that the proposed surrogate pairwise likelihood leads to a consistent and asymptotically normal estimator by effective communication without sharing individual patient-level data. We study the empirical performance of the proposed method through a systematic simulation study and an application with data of 14,215 COVID-19 patients from 230 clinical sites at UnitedHealth Group Clinical Research Database.
Results The proposed method was shown to perform close to the gold standard approach under extensive simulation settings. When the event rate is <5%, the relative bias of the proposed estimator is 30% smaller than that of the meta-analysis estimator. The proposed method retained high accuracy across different sample sizes and event rates compared with meta-analysis. In the data evaluation, the proposed estimate has a relative bias <9% when the event rate is <1%, whereas the meta-analysis estimate has a relative bias at least 10% higher than that of the proposed method.
Conclusions Our simulation study and data application demonstrate that the proposed distributed algorithm provides an estimator that is robust to heterogeneity in event rates when effectively integrating data from multiple clinical sites. Our algorithm is therefore an effective alternative to both meta-analysis and existing distributed algorithms for modeling heterogeneous multi-site binary outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by the National Institutes of Health grants 1R01LM012607 and 1R01AI130460.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is the IRB exemption from UnitedHealth Group Office of Human Research Affairs (OHRA). The action is approved by the OHRA. Please see the following certificate of action: Documents: - An efficient distributed algorithm with application to COVID-19 data from heterogeneous clinical sites paper, received 10/29/2020 Regulatory Determinations: The research was determined to qualify as negligible risk and is permissible under exempt category 4 (ii). The research was determined to be exempt as the activities did not identify subjects directly or through identifiers via the claims database, subjects were not contacted, and investigators will not re - identify subjects. Notes & Reminders: Annual renewal of this project is not required. If any aspects of the project change, please engage the OHRA to determine whether any additional research determinations or risk assessments are needed. Please inform the OHRA when they project and any associated data utilization have concluded.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The dataset is composed of 14,215 hospitalized patients who were diagnosed with COVID-19 prior to June 29, 2020 from a single large national health insurer at UnitedHealth Group Clinical Research Database, which covers a broad swath of the population. The data are from multiple EHR systems including EPIC, Cerner, and others. The data are proprietary and are not available for public use but can be made available to editors and their approved auditors under a data use agreement to confirm the findings of the current study.
